| Previous || Home || Next |
| Title: Blackstone hired to sell drugmaker Stiefel -source |
|
) to try and sell the U.S. skincare business, a
person familiar with the situation said on Friday.
The privately-held pharmaceutical maker is the world's largest independent dermatology company and is viewed as a potentially attractive asset for major drugmakers, with a possible price tag of more than $3 billion. "It's definitely for sale. They (Blackstone) have just started contacting parties," the source said. Blackstone -- which owns a substantial minority stake in Stiefel -- and the company's family owners are seeking a speedy sale, the source added. The Wall Street Journal first reported that Stiefel was considering selling itself in a deal that could be worth several billions of dollars. [ID:nLK378280] Officials at Stiefel and Blackstone could not immediately be reached for comment by Reuters. (Reporting by Ben Hirschler; editing by John Stonestreet) Full article |
| Other article: |
| Blackstone hired to sell drugmaker Stiefel -source |
| RPT-BRIEF-Fiat denies assumption of Chrysler debt |
| Market Chatter -- Corporate finance press digest |
| UPDATE 1-Glaxo gets $256 mln from selling down Quest stake |
Tag site
| World News Economic Global Markets |
| Private Capital Mergers & Acquisitions |
| Media Deals |
| Deals |